about
Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cellsA Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction.The Favorable Effect of Mesenchymal Stem Cell Treatment on the Antioxidant Protective Mechanism in the Corneal Epithelium and Renewal of Corneal Optical Properties Changed after Alkali BurnsTargeted neural differentiation of murine mesenchymal stem cells by a protocol simulating the inflammatory site of neural injury.Transfer of mesenchymal stem cells and cyclosporine A on alkali-injured rabbit cornea using nanofiber scaffolds strongly reduces corneal neovascularization and scar formation.Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.The enzymatic de-epithelialization technique determines denuded amniotic membrane integrity and viability of harvested epithelial cells.Treatment of alkali-injured cornea by cyclosporine A-loaded electrospun nanofibers - An alternative mode of therapy.The Supportive Role of Insulin-Like Growth Factor-I in the Differentiation of Murine Mesenchymal Stem Cells into Corneal-Like Cells.Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface.A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotypeDistinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cellsCyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppressionDiscontinuous transcription of ribosomal DNA in human cells
P50
Q34291269-062EA322-A79C-4E92-8DB9-33D3DEBB1881Q35975412-DB84D2CB-49B4-466C-A631-7136561658BEQ36530413-6C4BE48D-A858-4211-909A-45A88ECA9A1DQ48105363-827A2591-9E8C-456E-B5C7-5802D2C9A8D9Q51550661-DA8B2DBD-638B-4844-B80D-C3A81173346BQ51703801-56B2BC6A-77B9-4019-855D-D9CC8270B0C2Q52627929-EA5F4959-9D09-408F-BE6C-412D4A3D6A73Q53099082-92E1D5DB-B1B2-4B6D-8FB5-3E6493928623Q53128762-732D01C3-DE99-4886-9835-7879FF019A97Q54718619-3183607F-7A98-4F3F-B8D7-518E810D996BQ63437246-8A483D4D-5EB2-4AE7-B4B1-60091BDC5420Q63437254-97A9AE50-8FA0-4821-B617-24B43560DC9FQ63437257-85F2C80C-1F2F-4311-A680-9144EBAFBC9FQ89972137-7F6BD88A-B321-422E-AD49-7E2057FAEC77
P50
description
investigador
@es
researcher
@en
name
Peter Trosan
@en
type
label
Peter Trosan
@en
prefLabel
Peter Trosan
@en
P31
P496
0000-0002-4836-0887